Efficacy News and Research

RSS
Ragweed allergy sublingual immunotherapy: an interview with Dr. Peter Creticos, Johns Hopkins University School of Medicine

Ragweed allergy sublingual immunotherapy: an interview with Dr. Peter Creticos, Johns Hopkins University School of Medicine

FDA accepts Teva Pharmaceutical's sNDA for COPAXONE

FDA accepts Teva Pharmaceutical's sNDA for COPAXONE

Whiplash therapy: an interview with Dr Williamson and Dr Williams, University of Warwick

Whiplash therapy: an interview with Dr Williamson and Dr Williams, University of Warwick

Researchers develop new gene therapy to thwart potential influenza pandemic

Researchers develop new gene therapy to thwart potential influenza pandemic

Pacira Pharmaceuticals reports results of EXPAREL Phase 2/3 clinical trial for TKA

Pacira Pharmaceuticals reports results of EXPAREL Phase 2/3 clinical trial for TKA

LA BioMed researchers recognized for training next generation of physicians

LA BioMed researchers recognized for training next generation of physicians

New approach to battle prostate cancer

New approach to battle prostate cancer

Valeant Pharmaceuticals receives Complete Response Letter from FDA for efinaconazole NDA

Valeant Pharmaceuticals receives Complete Response Letter from FDA for efinaconazole NDA

Frutarom reports increased demand for natural ingredient targeting urinary incontinence in adults

Frutarom reports increased demand for natural ingredient targeting urinary incontinence in adults

Report finds increase in unintentional marijuana ingestions among young children

Report finds increase in unintentional marijuana ingestions among young children

Omthera to be acquired by AstraZeneca

Omthera to be acquired by AstraZeneca

EADV spring symposium: Bioalliance Pharma presents Sitavig study results

EADV spring symposium: Bioalliance Pharma presents Sitavig study results

Single injection of human neural stem cells improves acute spinal cord injuries in rats

Single injection of human neural stem cells improves acute spinal cord injuries in rats

Study examines effectiveness of VRET on agoraphobia, panic disorder

Study examines effectiveness of VRET on agoraphobia, panic disorder

OrbusNeich introduces COMBO Dual Therapy Stent

OrbusNeich introduces COMBO Dual Therapy Stent

OPKO reports more than 50% enrollment in phase 3 trial of Rayaldy for treatment of secondary hyperparathyroidism

OPKO reports more than 50% enrollment in phase 3 trial of Rayaldy for treatment of secondary hyperparathyroidism

Novel multiplex immunoassay approach to capture HIV antibodies

Novel multiplex immunoassay approach to capture HIV antibodies

Merck updates on preladenant clinical program for treatment of Parkinson's disease

Merck updates on preladenant clinical program for treatment of Parkinson's disease

Spring Bank Pharmaceuticals starts Phase I study of SB 9200 for treatment of HCV infection

Spring Bank Pharmaceuticals starts Phase I study of SB 9200 for treatment of HCV infection

DESolve bioresorbable coronary scaffold system safe and effective, shows low rates of late lumen loss

DESolve bioresorbable coronary scaffold system safe and effective, shows low rates of late lumen loss

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.